Advised Veeda Clinical Research on the sale of Veeda Laboratories

Transaction Summary

Advised Veeda Clinical Research on the sale of Veeda Laboratories, a specialist provider of biomarker laboratory services to global pharmaceutical and biotechnology industries to ICON plc.

Background

• Veeda Laboratories Ltd., a wholly owned subsidiary of Veeda Clinical Research Group was sold to ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries

• Veeda Laboratories is a specialist provider of biomarker laboratory services to global pharmaceutical and biotechnology industries

• Veeda Clinical Research is a full service global CRO specializing in the early clinical development of drugs. With state-of-the-art facilities in the UK, India and Belgium, Veeda provides a full range of services in Phase I and IIa clinical research, delivering expert, cost effective research solutions to the Pharmaceutical and Biotechnology Industries worldwide

 Transaction Highlights

• Strata structured, managed and successfully completed a highly competitive sale process

• Strata was able to secure the interest and attention of a large buyer universe

• Planning and preparation and the use of competitive tension were key to extracting maximum value

• The transaction significantly exceeded shareholder value expectations

• The transaction demonstrated Strata Partners’ extensive knowledge of the global CRO and the lab testing industry, senior relationships with leading pharma service industry players worldwide and our first class transaction execution skills